Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

Practical considerations for chimeric antigen receptor design and delivery.

Robyn A A Oldham^1,2, Jeffrey A Medin^1,2,3,4

¹a Department of Pediatrics , The Medical College of Wisconsin , Milwaukee , USA.

Expert Opinion on Biological Therapy

|June 7, 2017

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Improved lentivector-modified hematopoietic stem cell transplantation in the Townes mouse model of sickle cell disease.

Cytotherapy·2026

Same author

Tissue accessibility and thresholds in gene therapy for a lysosomal storage disorder.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

Reduced-intensity conditioning in LV-mediated gene therapy for Fabry disease targeting HSPCs.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial.

Clinical and translational medicine·2025

Same author

Cardiac dysfunction and altered gene expression in acid ceramidase-deficient mice.

American journal of physiology. Heart and circulatory physiology·2024

Same author

Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients.

Frontiers in immunology·2024

Chimeric antigen receptor (CAR) T-cell therapy is evolving with new designs and administration methods. Ongoing research aims to optimize CAR effectiveness and safety for broader cancer treatment applications.

Area of Science:

Immunology
Biotechnology
Oncology

Background:

Chimeric antigen receptor (CAR)-modified immune cells represent a rapidly advancing therapeutic strategy.
Since 1989, continuous innovation has led to more specialized and effective CAR designs.

Purpose of the Study:

To summarize current research on CAR design adaptations.
To review methods for CAR transgene delivery into effector cells.
To discuss the optimization of CAR therapy administration.

Main Methods:

Review of existing literature on CAR design variations.
Analysis of different CAR transgene transfer techniques.
Assessment of CAR therapy administration strategies.

Main Results:

Keywords:

Cancer T cell chimeric antigen receptor (CAR)gene therapy immunotherapy

More Related Videos

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Numerous adaptations for CAR components and administration have been explored.
Various methods for CAR transgene integration into effector cells are documented.

Conclusions:

Significant progress has been made in CAR therapy development and testing.
Further research is needed to determine optimal CAR variations and improve safety and anti-tumor efficacy.
Continued investigation is crucial for transitioning CAR therapy from clinical trials to standard cancer care.